Kymera Therapeutics Statistics
NASDAQ: KYMRHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
105.55-2.81 (-2.59%)
Market open · Delayed 15 min · as of Oct 8, 12:21 PM ET
Kymera Therapeutics by the numbers
Kymera Therapeutics has a market capitalization of $8.68 billion based on 82.26M shares outstanding. With trailing EPS of $-3.25, Kymera Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 7.8% below its 50-day average and 13.0% above its 200-day average.
Average daily trading volume is 698.42K shares, or about $73.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
KYMR valuation vs. peer median
| Metric | KYMR | Peer median | Difference |
|---|---|---|---|
| Market cap | $8.68B | $9.82B | -12% |
| Avg. volume | 698.42K | 1.82M | -62% |
Peer median across 8 companies: QGEN, KRYS, PCVX, TWST, RGEN, IBRX, TECH, IMVT.
Valuation
- Market cap
- $8.68B
- Price / sales (latest FY)
- 221.41
- EPS (TTM)
- $-3.25
- Shares outstanding
- 82.26M
Price and trading
- Previous close
- 108.35
- Open
- 106.52
- Day range
- 104.19 – 107.98
- 52-week range
- 55.26 – 130.05
- 52-week change
- +90.35%
- 50-day moving average
- 114.42
- Beta
- —
- Volume
- 294.40K
- Average volume
- 698.42K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 8.68B
- Forward Pe
- -20.76
- Eps
- -3.25
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 130.05
- Week52 Low
- 55.26
- Avg Volume
- 698.42K
- Shares Outstanding
- 82.26M
- Ma50
- 114.42
- Ma200
- 93.42
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -18.84%
- Pct From52w Low
- 91.00%